Guang‐Wen Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guang‐Wen Xu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Mingran Xie
Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei China
5 shared publications Mei‐Qing Xu
Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
4 shared publicationsCai‐Wei Li
Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
3 shared publicationsShi‐Bin Xu
Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
3 shared publicationsChang‐Qing Liu
Department of Thoracic Surgery, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China
2 shared publications- Han‐Ran Wu
Department of Thoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
2 shared publications
Latest Publications
- Open Access
- 22 January 2020
- Published by Wiley in Thoracic Cancer
- Vol. 11 (3) , 612-618
A prospective study examining the impact of uniportal video‐assisted thoracic surgery on the short‐term quality of life in patients with lung cancer
Background: The aim of this study was to evaluate the effect of uniportal and three‐portal VATS in lung cancer patients on the postoperative short‐term quality of life (QOL).Methods: A single‐center, prospective, nonrandomized study was performed on patients who underwent uniportal or three‐portal video‐assisted thoracoscopic surgery (VATS) lobectomy and systemic mediastinal lymph node dissection. QOL was measured before surgery at baseline and at one, two, four, and eight weeks after the operation. The measured data of normal distribution were indicated by the mean ± standard deviation, the independent sample t‐test was used among the groups, and the χ2 test was used to compare the counting. Non‐normal distribution of the measurement data was carried out using the Mann‐Whitney test.Results: Preoperative functional areas, symptom areas and overall health scores were similar in the two groups. The physical, role, emotional and social functions and overall health status of the uniportal group were significantly higher than those of the three‐portal group in postoperative time. The score of symptom field was higher in one week after operation, the score of two, four and eight weeks decreased gradually, but it was still above the preoperative level, and the fatigue and pain of the uniportal group were significantly lower than that of the three‐portal group.Conclusion: The advantages of uniportal VATS include a shorter hospital stay, more rapid recovery and superior cosmetic results compared to three‐portal VATS. Additionally, uniportal VATS is superior to three‐portal thoracoscopic surgery in terms of the immediate postoperative short‐term QOL.
- 22 January 2020
- Published by Wiley in Thoracic Cancer
- Vol. 11 (3) , 612-618
Open AccessA prospective study examining the impact of uniportal video‐assisted thoracic surgery on the short‐term quality of life in patients with lung cancer
Background: The aim of this study was to evaluate the effect of uniportal and three‐portal VATS in lung cancer patients on the postoperative short‐term quality of life (QOL).Methods: A single‐center, prospective, nonrandomized study was performed on patients who underwent uniportal or three‐portal video‐assisted thoracoscopic surgery (VATS) lobectomy and systemic mediastinal lymph node dissection. QOL was measured before surgery at baseline and at one, two, four, and eight weeks after the operation. The measured data of normal distribution were indicated by the mean ± standard deviation, the independent sample t‐test was used among the groups, and the χ2 test was used to compare the counting. Non‐normal distribution of the measurement data was carried out using the Mann‐Whitney test.Results: Preoperative functional areas, symptom areas and overall health scores were similar in the two groups. The physical, role, emotional and social functions and overall health status of the uniportal group were significantly higher than those of the three‐portal group in postoperative time. The score of symptom field was higher in one week after operation, the score of two, four and eight weeks decreased gradually, but it was still above the preoperative level, and the fatigue and pain of the uniportal group were significantly lower than that of the three‐portal group.Conclusion: The advantages of uniportal VATS include a shorter hospital stay, more rapid recovery and superior cosmetic results compared to three‐portal VATS. Additionally, uniportal VATS is superior to three‐portal thoracoscopic surgery in terms of the immediate postoperative short‐term QOL.
- 23 July 2019
- Published by Wiley in Anz Journal of Surgery
- Vol. 89 (9) , 1056-1060
Systematic mediastinal lymph node dissection outcomes and conversion rates of uniportal video‐assisted thoracoscopic lobectomy for lung cancer
Background: To evaluate the systematic mediastinal lymph node (LN) dissection outcomes and conversion rates of uniportal video‐assisted thoracoscopic surgery (UVATS).Methods: Patients with non‐small‐cell lung cancer who underwent video‐assisted thoracoscopic surgery (VATS) and systematic mediastinal LN dissection between January 2015 and January 2017 were retrospectively reviewed. We categorized the patients into two groups according to the different surgical approaches. Patients' clinical data were collected and compared. The index of estimated benefit from LN dissection was used to evaluate the therapeutic value of LN dissection for each station.Results: A total of 453 patients underwent VATS, including 197 patients in the UVATS group and 256 patients in the triportal VATS (TVATS) group. There were no significant differences in the 1‐, 2‐ and 3‐year survival rates of these two groups (P > 0.05). There were no statistically significant differences in the operative time, numbers and stations of LNs, numbers and stations of N2 LNs, conversion rate or postoperative complications. The UVATS group had less intraoperative blood loss, a shorter duration of hospital stay, less chest tube drainage and a shorter duration of chest tube drainage than the TVATS group (P < 0.05). The conversion rates in the UVATS and TVATS groups were 5.1% and 4.3%, respectively, and the difference was not significant. The same degree of LN sampling was achieved in both groups.Conclusion: UVATS permits the same degree of LN sampling as TVATS without a difference in the conversion rate.
- 23 July 2019
- Published by Wiley in Anz Journal of Surgery
- Vol. 89 (9) , 1056-1060
Systematic mediastinal lymph node dissection outcomes and conversion rates of uniportal video‐assisted thoracoscopic lobectomy for lung cancer
Background: To evaluate the systematic mediastinal lymph node (LN) dissection outcomes and conversion rates of uniportal video‐assisted thoracoscopic surgery (UVATS).Methods: Patients with non‐small‐cell lung cancer who underwent video‐assisted thoracoscopic surgery (VATS) and systematic mediastinal LN dissection between January 2015 and January 2017 were retrospectively reviewed. We categorized the patients into two groups according to the different surgical approaches. Patients' clinical data were collected and compared. The index of estimated benefit from LN dissection was used to evaluate the therapeutic value of LN dissection for each station.Results: A total of 453 patients underwent VATS, including 197 patients in the UVATS group and 256 patients in the triportal VATS (TVATS) group. There were no significant differences in the 1‐, 2‐ and 3‐year survival rates of these two groups (P > 0.05). There were no statistically significant differences in the operative time, numbers and stations of LNs, numbers and stations of N2 LNs, conversion rate or postoperative complications. The UVATS group had less intraoperative blood loss, a shorter duration of hospital stay, less chest tube drainage and a shorter duration of chest tube drainage than the TVATS group (P < 0.05). The conversion rates in the UVATS and TVATS groups were 5.1% and 4.3%, respectively, and the difference was not significant. The same degree of LN sampling was achieved in both groups.Conclusion: UVATS permits the same degree of LN sampling as TVATS without a difference in the conversion rate.
- Open Access
- 18 March 2019
- Published by Wiley in Thoracic Cancer
- Vol. 10 (4) , 988-991
Increased expression of TRPV1 in patients with acute or chronic cough after lung cancer surgery
Background: We investigated preoperative and postoperative TRPV1, bradykinin (BK), and prostaglandin e‐2 (PGE2) levels in patients who underwent lung cancer surgery and evaluated the correlations between these levels and the development of acute or chronic cough after surgery. Methods: We evaluated 60 patients with non‐small cell lung cancer who underwent lobectomy at our center between August and October 2018. TRPV1, BK, and PGE2 levels were determined by enzyme‐linked immunosorbent assay and postoperative cough was assessed using the visual analog scale (VAS). Results: The postoperative serum TRPV1, BK, and PEG2 levels of the 60 patients were significantly higher than the preoperative levels ( P < 0.001). Thirty‐five patients (58.3%) were diagnosed with acute cough (VAS ≥ 60 mm), and 25 were diagnosed with non‐acute cough (41.7%). Three days after surgery, the serum TRPV1, BK, and PGE2 levels were significantly higher in the acute cough group than in the non‐acute cough group ( P < 0.001). Twenty‐two patients (36.7%) were diagnosed with chronic cough (VAS ≥ 60 mm), and 25 (62.3%) were diagnosed with non‐chronic cough. Eight weeks after surgery, the serum TRPV1, BK, and PGE2 levels were significantly higher in the chronic cough group than in the non‐chronic cough group ( P < 0.05). Conclusions: The postoperative TRPV1, BK and PGE2 levels were significantly higher than the preoperative levels. The TRPV1 level was also higher in patients with an acute or chronic cough than in patients without. Postoperative acute or chronic cough symptoms can be improved and alleviated by blocking the TRPV1 pathway.
- 18 March 2019
- Published by Wiley in Thoracic Cancer
- Vol. 10 (4) , 988-991
Open AccessIncreased expression of TRPV1 in patients with acute or chronic cough after lung cancer surgery
Background: We investigated preoperative and postoperative TRPV1, bradykinin (BK), and prostaglandin e‐2 (PGE2) levels in patients who underwent lung cancer surgery and evaluated the correlations between these levels and the development of acute or chronic cough after surgery. Methods: We evaluated 60 patients with non‐small cell lung cancer who underwent lobectomy at our center between August and October 2018. TRPV1, BK, and PGE2 levels were determined by enzyme‐linked immunosorbent assay and postoperative cough was assessed using the visual analog scale (VAS). Results: The postoperative serum TRPV1, BK, and PEG2 levels of the 60 patients were significantly higher than the preoperative levels ( P < 0.001). Thirty‐five patients (58.3%) were diagnosed with acute cough (VAS ≥ 60 mm), and 25 were diagnosed with non‐acute cough (41.7%). Three days after surgery, the serum TRPV1, BK, and PGE2 levels were significantly higher in the acute cough group than in the non‐acute cough group ( P < 0.001). Twenty‐two patients (36.7%) were diagnosed with chronic cough (VAS ≥ 60 mm), and 25 (62.3%) were diagnosed with non‐chronic cough. Eight weeks after surgery, the serum TRPV1, BK, and PGE2 levels were significantly higher in the chronic cough group than in the non‐chronic cough group ( P < 0.05). Conclusions: The postoperative TRPV1, BK and PGE2 levels were significantly higher than the preoperative levels. The TRPV1 level was also higher in patients with an acute or chronic cough than in patients without. Postoperative acute or chronic cough symptoms can be improved and alleviated by blocking the TRPV1 pathway.
- Open Access
- 15 March 2019
- Published by Wiley in Thoracic Cancer
- Vol. 10 (4) , 898-903
Analysis of factors related to chronic cough after lung cancer surgery
Background: In this study, we investigated the relationship between chronic cough and clinicopathological features in postoperative patients with non‐small cell lung cancer (NSCLC) and evaluated the effectiveness of acupuncture therapy for the treatment of postoperative chronic cough in patients with NSCLC. Methods: We retrospectively evaluated 171 patients with NSCLC who received lobectomy at our center between September 2017 and February 2018. The Mandarin Chinese version of the Leicester Cough Questionnaire (LCQ‐MC) was used to evaluate the degree of cough in patients. Postoperative cough was assessed by a visual analog scale (VAS). Results: The total LCQ‐MC score for the whole group was 19.79 ± 0.53 before surgery and 18.40 ± 0.70 after surgery (p < 0.001). Logistic regression analysis showed that right lung cancer, difficult airway, acute cough and history of COPD were independent predictors of chronic cough. Of the 68 patients diagnosed with chronic cough, 41 received acupuncture therapy (acupuncture therapy group), and 27 received no acupuncture therapy (no therapy group). No significant difference was found between the two groups in terms of their LCQ‐MC scores at eight weeks after surgery (p = 0.756). However, the acupuncture therapy group had a significantly higher LCQ‐MC score than the no therapy group at 10 weeks after surgery (p = 0.002). Conclusions: Right lung cancer, difficult airway, acute cough, and history of COPD are independent predictors of chronic cough after surgery. For patients with chronic cough, acupuncture therapy can shorten the recovery time and improve quality of life after surgery.
- 15 March 2019
- Published by Wiley in Thoracic Cancer
- Vol. 10 (4) , 898-903
Open AccessAnalysis of factors related to chronic cough after lung cancer surgery
Background: In this study, we investigated the relationship between chronic cough and clinicopathological features in postoperative patients with non‐small cell lung cancer (NSCLC) and evaluated the effectiveness of acupuncture therapy for the treatment of postoperative chronic cough in patients with NSCLC. Methods: We retrospectively evaluated 171 patients with NSCLC who received lobectomy at our center between September 2017 and February 2018. The Mandarin Chinese version of the Leicester Cough Questionnaire (LCQ‐MC) was used to evaluate the degree of cough in patients. Postoperative cough was assessed by a visual analog scale (VAS). Results: The total LCQ‐MC score for the whole group was 19.79 ± 0.53 before surgery and 18.40 ± 0.70 after surgery (p < 0.001). Logistic regression analysis showed that right lung cancer, difficult airway, acute cough and history of COPD were independent predictors of chronic cough. Of the 68 patients diagnosed with chronic cough, 41 received acupuncture therapy (acupuncture therapy group), and 27 received no acupuncture therapy (no therapy group). No significant difference was found between the two groups in terms of their LCQ‐MC scores at eight weeks after surgery (p = 0.756). However, the acupuncture therapy group had a significantly higher LCQ‐MC score than the no therapy group at 10 weeks after surgery (p = 0.002). Conclusions: Right lung cancer, difficult airway, acute cough, and history of COPD are independent predictors of chronic cough after surgery. For patients with chronic cough, acupuncture therapy can shorten the recovery time and improve quality of life after surgery.
- Open Access
- 12 October 2018
- Published by Wiley in Thoracic Cancer
- Vol. 9 (12) , 1707-1715
Value of the preoperative neutrophil‐to‐lymphocyte ratio as a prognostic factor for long‐term survival in postoperative esophageal squamous cell carcinoma patients
Background: This study investigated the relationship between the neutrophil‐to‐lymphocyte ratio (NLR) and clinicopathological features and prognosis in patients with postoperative esophageal squamous cell carcinoma (ESCC).Methods: The preoperative NLR was evaluated in 419 patients who underwent esophagectomy for ESCC. A receiver operating characteristic (ROC) curve was plotted to verify the accuracy of the NLR for predicting survival. Correlation between the NLR and clinicopathological characteristics was analyzed using the χ2 test. Prognostic influence was calculated by using the Kaplan–Meier method and the difference was assessed by log‐rank test. Multivariate Cox regression models were applied to evaluate the independent prognostic value.Results: The cutoff value of the NLR was 2.998, the area under the curve was 0.735, and the sensitivity and specificity were 69.3% and 69.3%, respectively. Tumor length (P = 0.0317), lymph node metastasis (P = 0.0352), pathological tumor node metastasis (pTNM) stage (P = 0.0271), and postoperative radiotherapy (P = 0.0385) were significantly different between the groups. Multivariate analysis showed that pTNM stage (P = 0.0098), lymph node metastasis (P = 0.001), and NLR (P = 0.0022) were independent prognostic factors for survival. Moreover, when patients were stratified by TNM stage, the adverse effects of preoperative NLR on cancer‐specific survival were greater in patients with stage II and III ESCC and in patients with lymph node metastasis.Conclusions: The preoperative NLR is significantly correlated with long‐term prognosis in postoperative patients with ESCC, particularly in patients with lymph node metastasis and stage II and III ESCC.
- 12 October 2018
- Published by Wiley in Thoracic Cancer
- Vol. 9 (12) , 1707-1715
Open AccessValue of the preoperative neutrophil‐to‐lymphocyte ratio as a prognostic factor for long‐term survival in postoperative esophageal squamous cell carcinoma patients
Background: This study investigated the relationship between the neutrophil‐to‐lymphocyte ratio (NLR) and clinicopathological features and prognosis in patients with postoperative esophageal squamous cell carcinoma (ESCC).Methods: The preoperative NLR was evaluated in 419 patients who underwent esophagectomy for ESCC. A receiver operating characteristic (ROC) curve was plotted to verify the accuracy of the NLR for predicting survival. Correlation between the NLR and clinicopathological characteristics was analyzed using the χ2 test. Prognostic influence was calculated by using the Kaplan–Meier method and the difference was assessed by log‐rank test. Multivariate Cox regression models were applied to evaluate the independent prognostic value.Results: The cutoff value of the NLR was 2.998, the area under the curve was 0.735, and the sensitivity and specificity were 69.3% and 69.3%, respectively. Tumor length (P = 0.0317), lymph node metastasis (P = 0.0352), pathological tumor node metastasis (pTNM) stage (P = 0.0271), and postoperative radiotherapy (P = 0.0385) were significantly different between the groups. Multivariate analysis showed that pTNM stage (P = 0.0098), lymph node metastasis (P = 0.001), and NLR (P = 0.0022) were independent prognostic factors for survival. Moreover, when patients were stratified by TNM stage, the adverse effects of preoperative NLR on cancer‐specific survival were greater in patients with stage II and III ESCC and in patients with lymph node metastasis.Conclusions: The preoperative NLR is significantly correlated with long‐term prognosis in postoperative patients with ESCC, particularly in patients with lymph node metastasis and stage II and III ESCC.